Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D)

Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D) American Journal of Gastroenterology 113, 443 (March 2018). doi:10.1038/ajg.2017.486 Authors: Elmar Aigner, Alexandra Feldman, Daniel Neureiter, Christian Datz, Vlad Ratziu & Bernhard Paulweber
Source: The American Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research